Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merus NV

44.21
-1.2400-2.73%
Post-market: 44.19-0.0200-0.05%16:00 EDT
Volume:705.46K
Turnover:32.04M
Market Cap:3.05B
PE:-13.19
High:46.36
Open:45.63
Low:44.19
Close:45.45
Loading ...

Merus Price Target Maintained With a $85.00/Share by Needham

Dow Jones
·
02 Dec 2024

Merus NV (MRUS): Among the Most Promising Cancer Stocks According to Hedge Funds

Insider Monkey
·
23 Nov 2024

Merus Price Target Maintained With a $85.00/Share by Needham

Dow Jones
·
20 Nov 2024

PDS Biotechnology Corp (PDSB) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...

GuruFocus.com
·
15 Nov 2024

Is Merus N.V. (MRUS) Top Performing European Stock Heading into 2025?

Insider Monkey
·
13 Nov 2024

Merus to Present at Upcoming Investor Conferences

GlobeNewswire
·
07 Nov 2024

Merus Gets FDA Extension on Prescription Drug User Fee Act Goal Date for Zenocutuzumab to Feb. 4

MT Newswires Live
·
06 Nov 2024

Stock Track | Merus Shares Plunge as FDA Extends Review of Cancer Drug Candidate

Stock Track
·
05 Nov 2024

U.s-Listed Shares of Merus Nv Down 4.5% After FDA Extends Review of Co's Gene-Targeting Cancer Therapy

THOMSON REUTERS
·
05 Nov 2024

Merus: FDA Extends Review of Cancer Drug Zenocutuzumab to February

Dow Jones
·
05 Nov 2024

Merus Receives FDA extension of PDUFA for zenocutuzumab

GlobeNewswire
·
05 Nov 2024

Merus Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
02 Nov 2024

Analysts Offer Insights on Healthcare Companies: Merus (MRUS), IQVIA Holdings (IQV) and Voyager Therapeutics (VYGR)

TIPRANKS
·
01 Nov 2024

Merus Price Target Maintained With a $85.00/Share by Needham

Dow Jones
·
01 Nov 2024

Merus NV reports results for the quarter ended in January 1 - Earnings Summary

Reuters
·
01 Nov 2024

Merus N.V. (MRUS) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
31 Oct 2024

Merus Q3 EPS $(1.46) Misses $(0.89) Estimate, Sales $11.77M Beat $7.89M Estimate

Benzinga
·
31 Oct 2024

Merus Announces Financial Results for the Third Quarter 2024 and Provides Business Update

GlobeNewswire
·
31 Oct 2024